Skip to content
Close
SEARCH
Join Mailing List
Join Mailing List
IPC_HH_2025_L6A3551

CONFERENCE SPEAKERS, THEMES & PROGRAM HIGHLIGHTS

CONFIRMED SPEAKERS & THEMES

Theme 1: Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Brad Rovin The Ohio State University

Jonathan Barratt University of Leicester

Liz Lightstone Imperial College London

Marina Vivarelli Bambino Gesù Children's Hospital, IRCCS

Shikha Wadhwani UTMB
Theme 2: Past Lessons and Future Vision

Ana Malvar University of Buenos Aires

Carla Nester University of Iowa

Daniel Gale University College London

Heather Reich University of Toronto, University Health Network

Hiddo Heerspink University Medical Center Groningen

Katherine Tuttle Providence Health Care/University of Washington

Kirk Campbell NKF President, University of Pennsylvania

Laurel Damashek ISGD

Louise Oni University of Liverpool, UCL and Great Ormond Street Hospital for Children

Matthias Kretzler University of Michigan

Meg Jardine The University of Sydney

Muh Geot Wong The University of Sydney

Myda Khalid Indiana University School of Medicine

Patrick Nachman University of Minnesota

Priya Verghese Ann & Robert H. Lurie Children's Hospital

Sean Barbour The University of British Columbia

Suceena Alexander Christian Medical College

Vlado Perkovic UNSW Sydney
Theme 3: Emerging Biomarkers & Treatment Targets in GD Clinical Trials

Alessia Fornoni University of Miami

Alexander Duncan Walden Biosciences

Alice Brown Purespring Therapeutics

Jonathan Hogan Cabaletta Bio

Laura Barisoni Duke University

Laura Mariani University of Michigan

Nicola Tomas UKE Hamburg

Timothy Niewold The Hospital for Special Surgery

Vineet Gupta UTMB
Theme 4: Regulatory Advances

Abigail Smith Northwestern University

Adeera Levin Providence Health

Alex Mercer JAMCO Pharma Consulting

Barbara Gillespie ISGD, University of North Carolina

Brendon Neuen The George Institute for Global Health

Eloise Salmon University of Michigan

Jochen Reiser UTMB

Lesley Inker Tufts University School of Medicine

Tom Greene University of Utah Health
Theme 5: Breaking Barriers for Successful Trial Recruitment & Execution

Ali Poyan Mehr Kaiser Permanente, Bernard J. Tyson School of Medicine

Josh Tarnoff NephCure

Jula Inrig Travere Therapeutics

Jule Pinter UKE Hamburg

Ogo Egbuna Vertex Pharmaceuticals

Robert Brenner Vera Therapeutics

Sydney Tang The University of Hong Kong

Tobias B. Huber UKE Hamburg

Uptal Patel Biogen

LIST OF SESSIONS & SPEAKERS

Subject to change; full agenda forthcoming
  • Day 1: Friday Nov 13
  • Day 2: Saturday Nov 14
  • Day 3: Sunday November 15

PROGRAM BEGINS

Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Highlights from 2025-26 Conferences

Voice of the Patient

Emerging Biomarkers & Treatment Targets in GD Clinical Trials

  • Gene Delivery to the Podocyte
  • Cellular Therapy and Bispecific Antibodies for GD

Voice of Pharma: Translating Science into Therapeutics (Panel)

Past Lessons and Future Vision for GD Trials

  • Lessons Learned in Past GD trials
  • Evolving Trial Design & Endpoints

5:45 PM

PROGRAM ENDS

8:00 am

PROGRAM BEGINS

Voice of the FDA: What Keeps Us Up at Night (Panel)

Unmet Needs in Other Patient Populations

  • Pediatric Extrapolation
  • Trials in Transplant Patients

Should the Trial Proceed? DSMB Dilemmas

Voice of Healthcare Institutions' Leaders (Panel)

Poster Sessions

4:15 pm

PROGRAM ENDS

9:00 am

PROGRAM BEGINS

Breaking Barriers for Successful TrialRecruitment & Execution

  • GD Centers of Excellence
  • Recruiting More than 1 Patient at Each Site
  • Trial Operations Solutions

Voice of Pharma's C-Suite: What Keeps Us Up at Night (Panel)

Late Breaking Research

Voice of the Clinical Trials Village (Panel)

1:00 pm

PROGRAM ENDS